News
We continue to be sell-rated on Advanced Micro Devices, Inc. (NASDAQ:AMD) post the company’s Data Center and A.I. technology Premiere. Despite AMD CEO Lisa...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Buffett-style rational value picks | Top 95th percentile of financial bloggers according to TipRanks.Six years of long-horizon investment...
News
Footnote: 1. A composite is an aggregation of one or more portfolios into a single group that represents a particular investment objective or strategy....
News
This article was written by Follow The equity market is a powerful mechanism as daily fluctuations in price get aggregated to incredible wealth creation...
News
In the 2000 movie “Boiler Room,” a shady stockbroker scams a hapless investor into losing his life savings. Pressured by the broker, the investor...
News
If you are looking for an under-covered stock secured by a company with a substantial market share in a niche industry, then you’re in...
News
America May Now Be in a Youth-Cession: Consumers Over Age 60 Are Propping Up the Economy A big factor in the recent spending patterns...
News
The Kraft Heinz Company (NASDAQ:KHC) Evercore ISI 3rd Annual Consumer and Retail Conference June 15, 2023 1:15 PM ET Company Participants Andre Maciel –...
News
Millions of borrowers are awaiting an imminent decision by the Supreme Court on a pair of legal challenges to President Joe Biden’s signature student...
News
~ by Snehasish Chaudhuri, MBA (Finance). iShares Mortgage Real Estate Capped ETF (BATS:REM) is an exchange-traded fund (“ETF”) that invests in stocks of mortgage...
News
President Joe Biden will announce efforts Thursday to crack down on “junk fees” — hidden or obscure fees that surprise consumers when they’re buying...
News
Lanxess Aktiengesellschaft (OTCPK:LNXSF) has had some recent activity that signals value for the business on private markets. They created a J.V with Advent by...
News
Belite Bio (NASDAQ:BLTE) is a small company with multiple phase 3 trials targeting retinal degenerative eye diseases. The stock looks interesting, with late-stage trials...
